The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
PULMONX CORP COM | Common Stock | 745848101 | 197,304 | 11,843 | SH | SOLE | 0 | 0 | 11,843 | ||
SHARECARE INC COM CL A | Common Stock | 81948W104 | 482,961 | 254,190 | SH | SOLE | 0 | 0 | 254,190 | ||
SOPHIA GENETICS SA ORDINARY SHARES | Common Stock | H82027105 | 2,922,222 | 1,111,111 | SH | SOLE | 0 | 0 | 1,111,111 |